24-hour Mifepristone and Buccal Versus Mifepristone and Vaginal Misoprostol for Cervical Preparation for D&E

Completed · Phase 4 · Has a placebo group

Conditions studied: Abortion, Second Trimester

In brief

This study aims to compare mifepristone and buccal misoprostol to mifepristone and vaginal misoprostol for cervical preparation for second trimester dilation and evacuation (D\&E).

Key facts

Study ID

NCT03134183

Run by

Virginia Commonwealth University

People needed

70

Starts

2016-11-19

Expected to finish

2017-08-01

Last updated by the study team

2018-07-18

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• The study will enroll healthy English or Spanish-speaking women, over 18 years of age, eligible for non-urgent D\&E at 16 0/7 weeks to 20 6/7 weeks gestation, confirmed by sonogram, and willing/able to undergo informed consent.

You may not qualify if…

• Emergent need for D\&E, intrauterine infection, fetal demise, molar pregnancy, intolerance, allergy or contraindication to mifepristone or misoprostol

Where it is running

• Virginia Commonwealth University — Richmond, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.